United Therapeutics UTHR
$554.73 −$4.37 (-0.78%)
Market closed · Nov 20, 8:10 pm ET · Last extended-hours $550.23 -0.81%
Open$561.20
Prev close$559.10
Day range$551.77 – $563.12
Volume531.8K
Market cap$23.63B
P/E (TTM)20.9
Dividend yield–
Analyst view
ConsensusBuy
Analysts14
Average target$682.57+23.0% vs. price
- Buy 79%
- Hold 14%
- Sell 7%
Low $368.00Now $554.73Avg $682.57High $850.00
Recent rating changes
The last 20 actions on file set price targets from $368.00 to $850.00, averaging $689.40.
| Date | Firm | Rating | Target |
|---|---|---|---|
| 9 Nov 2026 | H.C. Wainwright | BUY | $660.00 |
| 5 Nov 2026 | TD Cowen | BUY | $700.00 |
| 5 Nov 2026 | Wells Fargo | BUY | $703.00 |
| 5 Nov 2026 | Leerink Partners | BUY | $725.00 |
| 4 Nov 2026 | Wells Fargo | BUY | $703.00 |
| 4 Nov 2026 | BTIG | BUY | $768.00 |
| 4 Nov 2026 | BofA Securities | HOLD | $650.00 |
| 4 Nov 2026 | RBC Capital | BUY | $725.00 |
| 28 Oct 2026 | J.P. Morgan | BUY | $695.00 |
| 26 Oct 2026 | Cantor Fitzgerald | BUY | $850.00 |
| 22 Oct 2026 | RBC Capital | BUY | $697.00 |
| 20 Oct 2026 | Raymond James | BUY | $717.00 |
| 20 Oct 2026 | Leerink Partners | BUY | $725.00 |
| 19 Oct 2026 | Leerink Partners | BUY | $725.00 |
| 16 Oct 2026 | Wells Fargo | BUY | $700.00 |
| 15 Oct 2026 | Goldman Sachs | SELL | $368.00 |
| 13 Oct 2026 | UBS | BUY | $725.00 |
| 12 Oct 2026 | Leerink Partners | BUY | $685.00 |
| 9 Oct 2026 | BofA Securities | HOLD | $559.00 |
| 8 Oct 2026 | RBC Capital | BUY | $708.00 |
No comments yet — be the first to weigh in on UTHR.
Sign in to join the discussion.